Abbott India Limited Stock price NSE India S.E.

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Delayed NSE India S.E. 08:01:59 2024-03-28 am EDT 5-day change 1st Jan Change
27,121 INR +1.53% Intraday chart for Abbott India Limited -2.00% +18.68%
Sales 2024 * 59.19B 710M Sales 2025 * 65.76B 789M Capitalization 573B 6.87B
Net income 2024 * 11.88B 143M Net income 2025 * 13.45B 161M EV / Sales 2024 * 9.29 x
Net cash position 2024 * 22.66B 272M Net cash position 2025 * 26.6B 319M EV / Sales 2025 * 8.3 x
P/E ratio 2024 *
48.3 x
P/E ratio 2025 *
42.8 x
Employees 3,700
Yield 2024 *
1.09%
Yield 2025 *
1.25%
Free-Float 24.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.53%
1 week-2.00%
Current month-4.62%
1 month-5.21%
3 months+19.88%
6 months+21.23%
Current year+18.68%
More quotes
1 week
26 426.30
Extreme 26426.3
27 229.90
1 month
26 426.30
Extreme 26426.3
28 800.00
Current year
22 761.10
Extreme 22761.1
29 638.95
1 year
20 605.05
Extreme 20605.05
29 638.95
3 years
14 586.05
Extreme 14586.05
29 638.95
5 years
7 160.00
Extreme 7160
29 638.95
10 years
1 695.05
Extreme 1695.05
29 638.95
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Compliance Officer - 23-09-13
Members of the board TitleAgeSince
Director/Board Member 68 19-03-31
Chairman 81 67-12-31
Director/Board Member 67 95-12-31
More insiders
Date Price Change Volume
24-03-28 27,121 +1.53% 33,995
24-03-27 26,711 +0.04% 17,617
24-03-26 26,701 -1.35% 14,019
24-03-22 27,067 -2.19% 21,967
24-03-21 27,673 -0.06% 9,629

Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT

More quotes
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
  1. Stock
  2. Equities
  3. Stock Abbott India Limited
  4. Stock Abbott India Limited - NSE India S.E.